Significance of blood analysis in hemophiliacs co-infected with human immunodeficiency virus and hepatitis viruses

Table 2 Blood viral load, immune and biochemical markers in non-hemophiliac patients mean ± SEM

	Non-hemophiliac patients
	HBV	HCV	HIV
No.	17	14	20
HIV viral load1	Not applicable	Not applicable	1.4 × 102 (< 50-104)
HBV viral load	8.8 × 106 (2.6 × 103-108)	Not applicable	Not applicable
HCV viral load	Not applicable	9 × 105 (2.6 × 103-107)	Not applicable
CD42	53.53 ± 4.15	41.43 ± 3.04	18.25 ± 1.83
CD4/CD8	1.93 ± 0.3	2.08 ± 0.26	0.63 ± 0.06
ALT (U/L)	266.6 ± 79.4	92.64 ± 22.6	34.35 ± 11.7
AST (U/L)	297.5 ± 108	77.5 ± 10	30.15 ± 3.82
TBIL (mol/L)	113.4 ± 36	31 ± 5.8	14.18 ± 1.42
ALP (U/L)	110 ± 7.9	118 ± 19.7	45.44 ± 0.63
γ-GT (U/L)	95.9 ± 17.8	87.6 ± 22	26.75 ± 5.52
HA (ng/mL)	323.2 ± 64.6	424.14 ± 78	83.9 ± 15.25
CG (μg/dL)	2678 ± 409	2050 ± 485	410 ± 61
PC3 (μg/L)	196 ± 21	236 ± 36	159.6 ± 28.4
LN (ng/mL)	122.6 ± 7.2	118 ± 11	106.65 ± 5.24
IVC (ng/mL)	100 ± 11	124 ± 15.6	74 ± 11.7

¹Geometric mean viral loads and range of HIV RNA, HBV DNA and HCV RNA;

²Represented as percent of the total T cell (CD3+) population.